Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merilin Al Sharif

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pharmacological Research|August 17, 2021
Development of mode of action networks related to the potential role of PPARγ in respiratory diseasesMerilin Al Sharif
International Journal of Molecular Sciences|July 18, 2015
Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent AntagonistsFilip Fratev, Ivanka Tsakovska, Merilin Al Sharif, et al.
PPAR Research|April 29, 2014
Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPAR γ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver DiseaseMerilin Al Sharif, Petko Alov, Vessela Vitcheva, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 2, 2019
Molecular Modeling Approach to Study the PPARγ-Ligand InteractionsMerilin Al Sharif, Ivanka Tsakovska, Petko Alov, et al.
Natural Product Communications|November 15, 2018
ADME/Tox Properties and Biochemical Interactions of Silybin Congeners: In silico StudyAntonia Diukendjieva, Merilin Al Sharif, Petko Alov, et al.
Molecules (Basel, Switzerland)|May 28, 2022
New Potential Pharmacological Targets of Plant-Derived Hydroxyanthraquinones from <i>Rubia</i> sppPetko Alov, Merilin Al Sharif, Hristo Najdenski, et al.
Toxicology and Applied Pharmacology|October 24, 2017
Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox predictionMerilin Al Sharif, Petko Alov, Vessela Vitcheva, et al.
International Journal of Molecular Sciences|May 27, 2014
Molecular modelling study of the PPARγ receptor in relation to the mode of action/adverse outcome pathway framework for liver steatosisIvanka Tsakovska, Merilin Al Sharif, Petko Alov, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|May 26, 2019
In silico and in vivo studies of Astragalus glycyphylloides saponin(s) with relevance to metabolic syndrome modulationMerilin Al Sharif, Vessela Vitcheva, Rumyana Simeonova, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 17, 2017
Molecular determinants of PPARγ partial agonism and related in silico/in vivo studies of natural saponins as potential type 2 diabetes modulatorsMerilin Al Sharif, Petko Alov, Antonia Diukendjieva, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmacological Research|August 17, 2021
Development of mode of action networks related to the potential role of PPARγ in respiratory diseasesMerilin Al Sharif
International Journal of Molecular Sciences|July 18, 2015
Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent AntagonistsFilip Fratev, Ivanka Tsakovska, Merilin Al Sharif, et al.
PPAR Research|April 29, 2014
Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPAR γ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver DiseaseMerilin Al Sharif, Petko Alov, Vessela Vitcheva, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 2, 2019
Molecular Modeling Approach to Study the PPARγ-Ligand InteractionsMerilin Al Sharif, Ivanka Tsakovska, Petko Alov, et al.
Natural Product Communications|November 15, 2018
ADME/Tox Properties and Biochemical Interactions of Silybin Congeners: In silico StudyAntonia Diukendjieva, Merilin Al Sharif, Petko Alov, et al.
Molecules (Basel, Switzerland)|May 28, 2022
New Potential Pharmacological Targets of Plant-Derived Hydroxyanthraquinones from <i>Rubia</i> sppPetko Alov, Merilin Al Sharif, Hristo Najdenski, et al.
Toxicology and Applied Pharmacology|October 24, 2017
Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox predictionMerilin Al Sharif, Petko Alov, Vessela Vitcheva, et al.
International Journal of Molecular Sciences|May 27, 2014
Molecular modelling study of the PPARγ receptor in relation to the mode of action/adverse outcome pathway framework for liver steatosisIvanka Tsakovska, Merilin Al Sharif, Petko Alov, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|May 26, 2019
In silico and in vivo studies of Astragalus glycyphylloides saponin(s) with relevance to metabolic syndrome modulationMerilin Al Sharif, Vessela Vitcheva, Rumyana Simeonova, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 17, 2017
Molecular determinants of PPARγ partial agonism and related in silico/in vivo studies of natural saponins as potential type 2 diabetes modulatorsMerilin Al Sharif, Petko Alov, Antonia Diukendjieva, et al.
Pageof 2